Francesco Greco1, Roberto Tacchino. 1. Department of Surgery, Clinica Castelli, Via Giuseppe Mazzini 11, 24128, Bergamo, Italy, drgrecofra@hotmail.com.
Abstract
BACKGROUND: Malabsorptive interventions are recognized as procedure of choice in metabolic surgery and the best strategy for re-do surgery when restriction failed. We describe a novel procedure, the ileal food diversion, an easy and effective non-restrictive one-anastomosis gastric bypass. METHODS: We report the preliminary results of a series of 68 consecutive patients performed by two surgeons in two different hospitals since 2009 (49 females, 13 re-do surgeries). RESULTS: Mean operating time was 65 min. All operations were performed by laparoscopy (three-trocar technique in 44 cases and 24 single-incision laparoscopies). Median follow-up is 9.6 months (range 2-48). Diabetes resolution was accomplished in 80% of patients. Average BMI decreases from 44 to 27 after 24 months. CONCLUSIONS: Ileal food diversion is an interesting option in super-obese patients, re-do surgery and patients with metabolic syndrome. Technical considerations, physiological assumptions and rationale were discussed.
BACKGROUND: Malabsorptive interventions are recognized as procedure of choice in metabolic surgery and the best strategy for re-do surgery when restriction failed. We describe a novel procedure, the ileal food diversion, an easy and effective non-restrictive one-anastomosis gastric bypass. METHODS: We report the preliminary results of a series of 68 consecutive patients performed by two surgeons in two different hospitals since 2009 (49 females, 13 re-do surgeries). RESULTS: Mean operating time was 65 min. All operations were performed by laparoscopy (three-trocar technique in 44 cases and 24 single-incision laparoscopies). Median follow-up is 9.6 months (range 2-48). Diabetes resolution was accomplished in 80% of patients. Average BMI decreases from 44 to 27 after 24 months. CONCLUSIONS: Ileal food diversion is an interesting option in super-obesepatients, re-do surgery and patients with metabolic syndrome. Technical considerations, physiological assumptions and rationale were discussed.
Authors: Sérgio Santoro; Carlos E Malzoni; Manoel C P Velhote; Fábio Q Milleo; Marco A Santo; Sidney Klajner; Durval Damiani; João G Maksoud Journal: Obes Surg Date: 2006-10 Impact factor: 4.129
Authors: Maurizio De Luca; Giacomo Piatto; Giovanni Merola; Jacques Himpens; Jean-Marc Chevallier; Miguel-A Carbajo; Kamal Mahawar; Alberto Sartori; Nicola Clemente; Miguel Herrera; Kelvin Higa; Wendy A Brown; Scott Shikora Journal: Obes Surg Date: 2021-05-03 Impact factor: 4.129
Authors: Mervyn Deitel; Kuldeepak S Kular; Mario Musella; Miguel A Carbajo; Robert Rutledge; Pradeep Chowbey; Enrique Luque-de-Leon; Karl P Rheinwalt; Roger Luciani; Gurvinder S Jammu; David E Hargroder; Arun Prasad Journal: Obes Surg Date: 2016-12 Impact factor: 4.129
Authors: Maurizio De Luca; Tiffany Tie; Geraldine Ooi; Kelvin Higa; Jacques Himpens; Miguel-A Carbajo; Kamal Mahawar; Scott Shikora; Wendy A Brown Journal: Obes Surg Date: 2018-05 Impact factor: 4.129